About Biopath Intelligence
Regulatory intelligence and operational consulting for life sciences companies operating in China.
Who We Are
Biopath Intelligence provides regulatory intelligence and operational consulting for life sciences companies operating in China.
We support global organizations in navigating Human Genetic Resources (HGR) compliance, sample import and export pathways, clinical trial operations, and regulatory requirements in China.
Our work connects regulatory interpretation with operational execution to enable clear, implementable decision-making.
Why Biopath
Industry Experience
More than 15 years of experience in clinical trial operations, central laboratory management and quality systems.
HGR Regulatory Expertise
Hands-on experience in Human Genetic Resources compliance interpretation, filing strategy, and cross-border sample movement pathways.
Operational Execution
Designing implementable solutions aligned with clinical trial workflows, laboratory operations, and site-level constraints.
Cross-Border Coordination
Supporting international life sciences organizations operating in China with clear regulatory interpretation and coordination.
Areas of Focus
Human Genetic Resources (HGR) Compliance
Regulatory interpretation, filing strategy, and cross-border sample movement requirements.
Clinical Trial Operations
Operational governance, site execution, and compliance alignment across clinical workflows.
Sample Import & Export Pathways
End-to-end cross-border logistics strategy under China regulatory framework.
Regulatory Intelligence
Continuous monitoring and interpretation of China life sciences regulatory developments.
Need Guidance on China Regulatory Pathways?
Whether you are planning a clinical study, moving samples across borders, or evaluating HGR requirements, Biopath can help identify the appropriate regulatory pathway.
We will review your inquiry and respond within 2 business days.